Table 1.
Model parameters (transition probabilities, screening test characteristics, quality of life, and costs), baseline values, and references.
Table 2.
Incidence, mortality, cost, effectiveness, ICER, and undiscounted ICER of 11 strategies compared with no screening strategy.
Fig 1.
Cost-effectiveness of 11 different strategies for cervical screening.
Strategies standing on the curve are dominant strategies, indicating that they cost less and had more effect. Strategies located out of the curve are dominated strategies, i.e. their costs were much higher than their effects.
Table 3.
The most cost-effective strategies (CES) based on different calculation methods.
The cost-effectiveness of 11 strategies were estimated with different methods. Effectiveness was measured with QALY, LYG, and undiscounted QALY.